SCHEMBL1103192

SCHEMBL1103192

c1ccc2c(c1)CCc1ccccc1N2c1c2ccccc2c(-c2ccc3ccccc3c2)c2ncccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.37
ALDH1A1 P00352 4/20 0.36
LMNA P02545 4/20 0.36
KDM4E B2RXH2 4/20 0.36
MAPT P10636 3/20 0.36
HPGD P15428 3/20 0.36
POLB P06746 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KMT2A Q03164 3/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
HTT P42858 2/20 0.35
USP2 O75604 1/20 0.35
TP53 P04637 1/20 0.35
ALOX12 P18054 1/20 0.35
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35
AKT1 P31749 1/20 0.34
GLA P06280 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
CYP17A1 P05093 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1103075 0.85 MAPT (0.39) TSHRALDH1A1LMNAKDM4EMAPT
SCHEMBL1103182 0.85 AKT1 (0.36) TSHRALDH1A1LMNAKDM4EMAPT
SCHEMBL1103190 0.85 BCHE (0.36) ALDH1A1LMNAKDM4EMAPTHPGD
SCHEMBL1103181 0.83 AKT1 (0.35) ALDH1A1LMNAKDM4EMAPTHPGD
SCHEMBL1103177 0.83 AKT1 (0.33) ALDH1A1LMNAKDM4EMAPTHPGD
SCHEMBL1102785 0.81 CYP11B1 (0.39) KMT2ACYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL1103242 0.81 TSHR (0.40) TSHRALDH1A1LMNAKDM4EMAPT
SCHEMBL1102903 0.79 KDM4E (0.43) TSHRALDH1A1LMNAKDM4EMAPT
SCHEMBL1103555 0.79 MET (0.39) LMNAKDM4EMAPTSMN1; SMN2KMT2A
SCHEMBL1103179 0.78 TUBB4A (0.38) TSHRALDH1A1LMNAKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 TSHR 4653/4885ALDH1A1 1015/4885LMNA 2738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.